Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
20.91
+3.15 (17.74%)
At close: Nov 6, 2026, 4:00 PM EST
21.00
+0.09 (0.43%)
After-hours: Nov 6, 2026, 7:54 PM EST
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $719.07 million as of November 6, 2026. It is the 11,811th most valuable company in the world and the 2,431st biggest in the United States. Its market cap has increased by 396.86% in one year.
Market Cap
719.07M
Enterprise Value
578.37M
1-Year Change
396.86%
Global Rank
Country Rank
#2,431 United States
Category
ChartMarket Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $719.07M, an increase of 1,139.66%. That is a compound annual growth rate of 69.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 732.52M | 278.77% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 760.27M |
| Rigel Pharmaceuticals | 740.66M |
| Solid Biosciences | 735.51M |
| OmniAb | 733.68M |
| Cullinan Therapeutics | 727.85M |
| Ardelyx | 723.95M |
| Arbutus Biopharma | 723.13M |
| Sana Biotechnology | 709.48M |